Alawi, Sittie Aina U.
HRN: 27-39-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2025
CEFUROXIME 1.5GM (VIAL)
08/09/2025
08/16/2025
IVT
1.5 GMS
ON CALL TO OR THEN Q 8
LTCS
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: